Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 303

1.

Cognitive and Behavioral Changes in Patients Treated With Droxidopa for Neurogenic Orthostatic Hypotension: A Retrospective Review.

McDonell KE, Shibao CA, Biaggioni I, Hartman A, Robertson D, Claassen DO.

Cogn Behav Neurol. 2019 Sep;32(3):179-184. doi: 10.1097/WNN.0000000000000198.

PMID:
31517701
2.

Human papillomavirus (HPV) vaccine and autonomic disorders: a position statement from the American Autonomic Society.

Barboi A, Gibbons CH, Axelrod F, Benarroch EE, Biaggioni I, Chapleau MW, Chelimsky G, Chelimsky T, Cheshire WP, Claydon VE, Freeman R, Goldstein DS, Joyner MJ, Kaufmann H, Low PA, Norcliffe-Kaufmann L, Robertson D, Shibao CA, Singer W, Snapper H, Vernino S, Raj SR; American Autonomic Society.

Clin Auton Res. 2019 Sep 2. doi: 10.1007/s10286-019-00608-w. [Epub ahead of print]

PMID:
31475305
3.

Initiation of droxidopa during hospital admission for management of refractory neurogenic orthostatic hypotension in severely ill patients.

McDonell KE, Preheim BA, Diedrich A, Muldowney JAS 3rd, Peltier AC, Robertson D, Biaggioni I, Shibao CA.

J Clin Hypertens (Greenwich). 2019 Aug 1. doi: 10.1111/jch.13619. [Epub ahead of print]

4.

What do we really know about supine hypertension in patients with orthostatic hypotension.

Jordan J, Tank J, Heusser K, Reuter H, Biaggioni I.

Curr Opin Cardiol. 2019 Jul;34(4):384-389. doi: 10.1097/HCO.0000000000000633.

PMID:
31021876
5.

Dopamine Beta-Hydroxylase Deficiency.

Garland EM, Biaggioni I.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019.
2003 Sep 4 [updated 2019 Apr 25].

6.

Six-Month Use of Droxidopa for Neurogenic Orthostatic Hypotension.

François C, Shibao CA, Biaggioni I, Duhig AM, McLeod K, Ogbonnaya A, Quillen A, Cannon J, Padilla B, Yue B, Orloski L, Kymes SM.

Mov Disord Clin Pract. 2019 Mar 7;6(3):235-242. doi: 10.1002/mdc3.12726. eCollection 2019 Mar.

PMID:
30949555
7.

Management of supine hypertension in patients with neurogenic orthostatic hypotension: scientific statement of the American Autonomic Society, European Federation of Autonomic Societies, and the European Society of Hypertension.

Jordan J, Fanciulli A, Tank J, Calandra-Buonaura G, Cheshire WP, Cortelli P, Eschlboeck S, Grassi G, Hilz MJ, Kaufmann H, Lahrmann H, Mancia G, Mayer G, Norcliffe-Kaufmann L, Pavy-Le Traon A, Raj SR, Robertson D, Rocha I, Reuter H, Struhal W, Thijs RD, Tsioufis KP, Gert van Dijk J, Wenning GK, Biaggioni I.

J Hypertens. 2019 Aug;37(8):1541-1546. doi: 10.1097/HJH.0000000000002078.

PMID:
30882602
8.

Vagal and Sympathetic Function in Neuropathic Postural Tachycardia Syndrome.

Jacob G, Diedrich L, Sato K, Brychta RJ, Raj SR, Robertson D, Biaggioni I, Diedrich A.

Hypertension. 2019 May;73(5):1087-1096. doi: 10.1161/HYPERTENSIONAHA.118.11803.

PMID:
30879357
9.

The face of postural tachycardia syndrome - insights from a large cross-sectional online community-based survey.

Shaw BH, Stiles LE, Bourne K, Green EA, Shibao CA, Okamoto LE, Garland EM, Gamboa A, Diedrich A, Raj V, Sheldon RS, Biaggioni I, Robertson D, Raj SR.

J Intern Med. 2019 Mar 12. doi: 10.1111/joim.12895. [Epub ahead of print]

PMID:
30861229
10.

Integrated Analysis of Droxidopa for the Treatment of Neurogenic Orthostatic Hypotension in Patients with Parkinson Disease.

Hauser RA, Biaggioni I, Hewitt LA, Vernino S.

Mov Disord Clin Pract. 2018 Nov 8;5(6):627-634. doi: 10.1002/mdc3.12695. eCollection 2018 Nov-Dec.

PMID:
30637284
11.

Synergistic Pressor Effect of Atomoxetine and Pyridostigmine in Patients With Neurogenic Orthostatic Hypotension.

Okamoto LE, Shibao CA, Gamboa A, Diedrich A, Raj SR, Black BK, Robertson D, Biaggioni I.

Hypertension. 2019 Jan;73(1):235-241. doi: 10.1161/HYPERTENSIONAHA.118.11790.

PMID:
30571543
12.

Orthostatic Hypotension in the Hypertensive Patient.

Biaggioni I.

Am J Hypertens. 2018 Nov 13;31(12):1255-1259. doi: 10.1093/ajh/hpy089.

PMID:
29982276
13.

Consensus statement on the definition of neurogenic supine hypertension in cardiovascular autonomic failure by the American Autonomic Society (AAS) and the European Federation of Autonomic Societies (EFAS) : Endorsed by the European Academy of Neurology (EAN) and the European Society of Hypertension (ESH).

Fanciulli A, Jordan J, Biaggioni I, Calandra-Buonaura G, Cheshire WP, Cortelli P, Eschlboeck S, Grassi G, Hilz MJ, Kaufmann H, Lahrmann H, Mancia G, Mayer G, Norcliffe-Kaufmann L, Pavy-Le Traon A, Raj SR, Robertson D, Rocha I, Struhal W, Thijs R, Tsioufis KP, van Dijk JG, Wenning GK.

Clin Auton Res. 2018 Aug;28(4):355-362. doi: 10.1007/s10286-018-0529-8. Epub 2018 May 15. Review.

14.

Letter by Jordan and Biaggioni Regarding Article, "Particulate Matter Exposure and Stress Hormone Levels: A Randomized, Double-Blind, Crossover Trial of Air Purification".

Jordan J, Biaggioni I.

Circulation. 2018 Mar 13;137(11):1205-1206. doi: 10.1161/CIRCULATIONAHA.117.031323. No abstract available.

PMID:
29530900
15.

Orthostatic heart rate changes in patients with autonomic failure caused by neurodegenerative synucleinopathies.

Norcliffe-Kaufmann L, Kaufmann H, Palma JA, Shibao CA, Biaggioni I, Peltier AC, Singer W, Low PA, Goldstein DS, Gibbons CH, Freeman R, Robertson D; Autonomic Disorders Consortium.

Ann Neurol. 2018 Mar;83(3):522-531. doi: 10.1002/ana.25170. Epub 2018 Mar 10.

16.

Mutations in CYB561 Causing a Novel Orthostatic Hypotension Syndrome.

van den Berg MP, Almomani R, Biaggioni I, van Faassen M, van der Harst P, Silljé HHW, Mateo Leach I, Hemmelder MH, Navis G, Luijckx GJ, de Brouwer APM, Venselaar H, Verbeek MM, van der Zwaag PA, Jongbloed JDH, van Tintelen JP, Wevers RA, Kema IP.

Circ Res. 2018 Mar 16;122(6):846-854. doi: 10.1161/CIRCRESAHA.117.311949. Epub 2018 Jan 17.

17.

Hypertension in Obese Black Women is Not Caused by Increased Sympathetic Vascular Tone.

Marinos A, Gamboa A, Celedonio JE, Preheim BA, Okamoto LE, Ramirez CE, Arnold AC, Diedrich A, Biaggioni I, Shibao CA.

J Am Heart Assoc. 2017 Nov 18;6(11). pii: e006971. doi: 10.1161/JAHA.117.006971.

18.

Fludrocortisone Is Associated With a Higher Risk of All-Cause Hospitalizations Compared With Midodrine in Patients With Orthostatic Hypotension.

Grijalva CG, Biaggioni I, Griffin MR, Shibao CA.

J Am Heart Assoc. 2017 Oct 12;6(10). pii: e006848. doi: 10.1161/JAHA.117.006848.

19.

Corrigendum to: Fall-related healthcare use and costs in neurogenic orthostatic hypotension with Parkinson's disease.

Francois C, Biaggioni I, Shibao C, Ogbonnaya A, Shih HC, Farrelly E, Ziemann A, Duhig A.

J Med Econ. 2017 Nov;20(11):1216. doi: 10.1080/13696998.2017.1376414. Epub 2017 Sep 8. No abstract available.

PMID:
28885073
20.

Integrated analysis of droxidopa trials for neurogenic orthostatic hypotension.

Biaggioni I, Arthur Hewitt L, Rowse GJ, Kaufmann H.

BMC Neurol. 2017 May 12;17(1):90. doi: 10.1186/s12883-017-0867-5.

Supplemental Content

Loading ...
Support Center